Clinical Trials Directory

Trials / Completed

CompletedNCT00564330

In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole

In Vivo Quantification of Dental Demineralisation Using Optical Coherence Tomography Before and After Double-blind, Randomised Treatment With Esomeprazole or Placebo of Patients With Dental Erosions

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Brain-Gut Research Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dental erosions in 30 male and female patients with proven abnormal gastrooesophageal reflux will be assessed clinically and using a novel optical coherence tomography (OCT) laser technique before and after double-blind randomization to antisecretory treatment with esomeprazole 20mg or placebo bid for 3 weeks. The primary objective is to quantify tooth substance loss as well as changes in optical reflectance and scattering of dental hard tissues with and without acid inhibition. Secondary objectives are: To compare standardised visual scoring with OCT quantification of reflux damage at the different time points on different teeth. To assess sex differences in OCT- quantified dental tissue loss.

Detailed description

Dental erosions in 30 male and female patients with proven abnormal gastrooesophageal reflux will be assessed clinically and using a novel optical coherence tomography (OCT) laser technique before and after double-blind randomization to antisecretory treatment with esomeprazole 20mg or placebo bid for 3 weeks. The primary objective is to quantify tooth substance loss as well as changes in optical reflectance and scattering of dental hard tissues with and without acid inhibition. Secondary objectives are: To compare standardised visual scoring with OCT quantification of reflux damage at the different time points on different teeth. To assess sex differences in OCT- quantified dental tissue loss

Conditions

Interventions

TypeNameDescription
DRUGEsomeprazole20mg bid
DRUGPlaceboPlacebo bid

Timeline

Start date
2007-11-01
Primary completion
2008-04-01
Completion
2008-05-01
First posted
2007-11-27
Last updated
2014-08-26

Source: ClinicalTrials.gov record NCT00564330. Inclusion in this directory is not an endorsement.